Bromopentacarbonylrhenium(I)
CAS: 14220-21-4
Ref. 3D-PAA22021
1g | A consultar | |
50mg | A consultar | |
100mg | A consultar | |
250mg | A consultar | |
500mg | A consultar |
Información del producto
- Bromopentacarbonylrhenium
- Carbon Monooxide - Bromorhenium (5:1)
- Pentacarbonylbromorhenium
- Pentacarbonylrhenium bromide
- Pentacarbonylrhenium bromide (Re(CO)<sub>5</sub>Br)
- Re(CO)<sub>5</sub>Br
- Rhenium(I) pentacarbonyl bromide
- Rhenium, bromopentacarbonyl-
- Rhenium, bromopentacarbonyl-, (OC-6-22)-
Bromopentacarbonylrhenium(I) is a molecule that has been shown to activate latent transcription factors and induce the production of growth factors. The compound is also able to reduce the effects of autoimmune disease in humans, as it has been shown to inhibit human liver cell proliferation and induce apoptosis in vitro. Bromopentacarbonylrhenium(I) is an excellent candidate for anticancer therapy due to its ability to bind epidermal growth factor (EGF). This binding causes a conformational change in the EGF, which activates downstream signaling pathways that are responsible for cancer cell growth and survival. Bromopentacarbonylrhenium(I) also has chelate-type ligands that can bind heavy metals such as copper or zinc, making it useful for treating infectious diseases caused by bacteria or fungi.
Propiedades químicas
Consulta técnica sobre: 3D-PAA22021 Bromopentacarbonylrhenium(I)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.